Netherlands vs South Sudan: Treatment success rate for patients treated for MDR-TB
Netherlands
91.0%
in 2021
South Sudan
94.0%
in 2022
Netherlands rank
21st
South Sudan rank
19th
Treatment success rate for patients treated for MDR-TB over time
- Netherlands
- South Sudan
How they compare
South Sudan currently reports 94.0% against 91.0% in Netherlands, a difference of 3.0%.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was South Sudan ahead.
Netherlands ranks 21st and South Sudan ranks 19th of 163 countries.
Across the 2 decades both report, Netherlands averaged higher in 1 and South Sudan in 1.
Head to head by decade
| Decade | Netherlands | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.0% | 87.7% | 4.7% | South Sudan |
| 2020s | 95.5% | 92.5% | 3.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Netherlands or South Sudan?
- South Sudan, at 94.0% against 91.0% in Netherlands as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Netherlands and South Sudan?
- 3.0%, with South Sudan ahead.
- How many years of comparable data are there for Netherlands and South Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do Netherlands and South Sudan rank globally for treatment success rate for patients treated for mdr-tb?
- Netherlands ranks 21st and South Sudan ranks 19th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.